MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report

T. Nguyen, V. Le, K. Vo, T. Tran (Ho Chi Minh, Viet Nam)

Meeting: 2024 International Congress

Abstract Number: 1341

Keywords: Ataxia: Etiology and Pathogenesis

Category: Ataxia

Objective: To present a rare case of gradually progressing cerebellar ataxia due to systemic autoimmune disease.

Background: Primary Sjögren’s syndrome (pSS) is an autoimmune disease, characterized by lymphocytic infiltration of exocrine glands such as salivary and lacrimal glands leading to xerostomia and xerophthalmia. Neurological manifestations in pSS are diverse and can involve both the central and peripheral nervous systems. Cerebellar ataxia is a rare but potentially debilitating manifestation of pSS, with limited reported cases in the literature (1), (2).

Method: Case report.

Results: A 56-year-old female presented with progressive gait instability and over 9 months. Neurological examination revealed ataxic gait with wide-based, limb incoordination, scanning speech, saccadic hypermetria, and rotational nystagmus consistent with cerebellar dysfunction. She experienced concurrent symptoms of dry eyes and dry mouth. Basic laboratory tests, including complete blood count, metabolic panel, lumbar puncture, and electromyography were within normal limits. Magnetic resonance imaging (MRI) of the brain demonstrated significant atrophy of the vermis of the cerebellum. Further studies showed positive anti-SSA and anti-SSB antibodies, combined with abnormal Schirmer’s test, confirming the diagnosis of Sjögren’s syndrome. Other autoimmune and paraneoplastic etiologies were excluded through extensive serological and imaging studies. The patient was treated with methylprednisolone, hydroxychloroquine, and rituximab. Her neurological symptoms improved slightly until her last visit.

Conclusion: Cerebellar ataxia is a rare but important neurological manifestation of pSS. This case highlights the need for clinicians to consider autoimmune etiologies in patients presenting with progressive ataxia, especially systemic autoimmune diseases such as pSS. Early recognition and management of neurological complications in pSS are crucial to prevent irreversible disability and improve patient outcomes.

References: 1. Chuah SL, Jobli AT, Wan SA, Teh CL. Cerebellar degeneration in primary Sjögren syndrome: a case report. Journal of medical case reports. 2021;15(1):526.
2. Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Annals of the rheumatic diseases. 2020;79(1):3-18.

To cite this abstract in AMA style:

T. Nguyen, V. Le, K. Vo, T. Tran. Progressive cerebellar ataxia in primary Sjögren’s syndrome: a case report [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/progressive-cerebellar-ataxia-in-primary-sjogrens-syndrome-a-case-report/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/progressive-cerebellar-ataxia-in-primary-sjogrens-syndrome-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley